Industry Trends

January 2020

See what has been happening in Asia’s pharma and personal care industries over the last weeks. What are experts and industry magazines talking about?

What has been happening?

Sunscreen active ingredients, bug-based beauty, swallowable x-ray pills, and more.  Find out what journals and industry experts have been discussing in the last four weeks.

Latest Industry Articles

Six Active Ingredients of Sunscreen Systemically Absorbed
Drugs.com

Sunscreen application is associated with geometric mean maximum plasma concentrations of all six active ingredients that exceed 0.5 ng/mL, according to a study published online.
Bug-based beauty: Singaporean biotech firm enlists soldier flies for more sustainable and purer chitosan
CosmeticsDesign-Asia

Singapore biotech start-up Insectta is rearing black soldier flies on its urban farm to produce a more sustainable and purer chitosan for the cosmetics industry.
Check-Cap’s Swallowable X-Ray Pill Allows For Prep-Free Colon Cancer Screenings
Forbes

Check-Cap’s swallow-able capsule uses low-dose x-rays to screen the digestive system while it moves along the GI tract. These scans are used to primarily detect precancerous polyps in the colon, making the capsule a preventative test, not a cancer treatment.
Development of an Innovative and Eco-Friendly UV Radiation Absorber, Based on Furan Moieties
Mdpi

The increasing concern about the environmental impact of ingredients largely used as sunscreens today is pushing research towards new frontiers for the synthesis and degradation potential of innovative sun protection structures.
‘Weak antibiotic pipeline’ poses threat to AMR fight
PharmaTimes

Of the 60 products in development, very few seem to show benefit over existing treatments.
Novel Drug Candidate Aims To Tackle Superbug Infections In Cystic Fibrosis Patients
Forbes

What makes the Antabio’s molecule candidate so unique is that it’s not an antibiotic. Antibiotics typically work by killing bacteria, whereas this molecule aims to disable the bacteria, making it less able to attack and inflame the lungs.
Early Antiretroviral Therapy May Not Achieve HIV Remission in Infants
Drugs.com

Starting antiretroviral therapy (ART) for HIV-infected infants within hours of birth does not seem to result in a higher proportion of infants who attain and sustain viral suppression on ART, according to a study.
Life Is Colorful presents the future of shade validation in color cosmetics
Cosmetics Business

To all color cosmetics brands out there: Have you ever wondered if you have the right colors in your product palette? Are there too many similar or even missing colors?
Most Children Do Not Have Positive Results to Antibiotic Challenge
Drugs.com

Most children with non-β-lactam antibiotic (NBLA) allergy can be delabeled, with positive results on allergy testing for only 18 percent, according to a study published online Dec. 3 in Pediatrics.
China cosmetics regulation: How is it changing in 2020 and beyond?
Cosmetics Business

On 3 January 2020 the Cosmetic Supervision and Administration Regulation was approved in China.
China passes Cosmetics Supervision and Administration Regulation
Cosmetics Business

The law replaces the Regulations on Hygienic Supervision of Cosmetics, which were first issued in 1989.
The top cosmetics regulatory issues on the agenda for APAC in 2020
CosmeticsDesign-Asia

CosmeticsDesign speaks to industry insiders for their expert analysis on the regulatory issues and trends that will affect the cosmetics industry in APAC in the new year, spanning China, Indonesia and Malaysia.
Most-read stories on China’s cosmetics industry
CosmeticsDesign-Asia

A round-up on CosmeticsDesign top stories on China’s lucrative personal care market, featuring the Chinese expansion ambitions of Black Chicken Remedies, AOBiome, Virospack and Symrise.
Fitch Solutions says drug price controls a threat to pharma multinationals
BusinessWorld

Fitch Solutions Macro Research said the government’s plan to impose price controls on a list of widely-used drugs will be positive for the market over the long term but will likely threaten the operations of multinational drugmakers, whose business models are based on expensive medicines under patent protection. Fitch Solutions said the price controls will likely restrict the growth of the pharmaceutical market over the short term.

Related Articles & Trends

Pharma & Personal Care Trends – November 2024

Pharma & Personal Care Trends – November 2024

Beauty 4.0: The state of the menopausal beauty market, New skin care line to address interest in Traditional Chinese Medicine and well-being surges, Benefits of transitioning to E-Cigarettes, and more. See what industry experts have been discussing in the last four weeks.

Pharma & Personal Care Trends – October 2024

Pharma & Personal Care Trends – October 2024

Sustainable cosmetic packaging innovations at Luxe Pack 2024, One or two-dose HPV vaccination, 3 ways to maintain glowy skin, and more. See what industry experts have been discussing in the last four weeks.

Pharma & Personal Care Trends – September 2024

Pharma & Personal Care Trends – September 2024

Rutin emerges as a sustainable alternative in sunscreen formulations, Infusing sustainability and transparency into skin care, Formulating menopausal skin care, and more. See what industry experts have been discussing in the last four weeks.

Industry News . Once a month . No spam